Literature DB >> 2228024

Thrombin and factor Xa enhance the production of interleukin-1.

A Jones1, C L Geczy.   

Abstract

Interleukin-1 (IL-1) plays a major role in inflammatory responses. Activation of coagulation and fibrin deposition typical of these reactions is mediated by macrophage procoagulants induced on stimulated macrophages. IL-1 activity in the supernatant of lipopolysaccharide (LPS)-stimulated guinea-pig macrophages was markedly enhanced by the presence of thrombin during macrophage activation. Although thrombin alone had no effect, inclusion of 1 mU/ml of thrombin with suboptimal levels of LPS produced a 200-fold increase in IL-1 activity, and further enhancement was observed with increasing doses of thrombin. The active site of thrombin was necessary for enhancement, as the serine esterase inhibitor di-isopropyl-fluorophosphate (DIP) and hirudin inhibited the synergy observed with LPS and thrombin. Prothrombin and Factor Xa also enhanced IL-1 production, although not to the same extent as thrombin. Factor Xa-like activity was demonstrated on the surface of LPS-stimulated macrophages. Both the Xa-like activity and IL-1 generated by LPS-stimulated cells were inhibited by heparin. Heparin with a high affinity for antithrombin III (anti-coagulant heparin; HAH) inhibited IL-1 generation, whereas low-affinity heparin (non-anticoagulant; LAH) had no effect. We show that proteases of the extrinsic coagulation cascade enhance IL-1 generation and propose that a Factor Xa-like activity present in activated macrophages, together with thrombin, may be important in IL-1 processing.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2228024      PMCID: PMC1384310     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  38 in total

1.  Functional prothrombinase complex assembly on isolated monocytes and lymphocytes.

Authors:  P B Tracy; M S Rohrbach; K G Mann
Journal:  J Biol Chem       Date:  1983-06-25       Impact factor: 5.157

Review 2.  The role of lymphokines in delayed-type hypersensitivity reactions.

Authors:  C L Geczy
Journal:  Springer Semin Immunopathol       Date:  1984

3.  Production of intra- and extracellular interleukin-1 (IL-1) by human monocytes.

Authors:  J L Lepe-Zuniga; I Gery
Journal:  Clin Immunol Immunopathol       Date:  1984-05

4.  Nucleotide sequence of human monocyte interleukin 1 precursor cDNA.

Authors:  P E Auron; A C Webb; L J Rosenwasser; S F Mucci; A Rich; S M Wolff; C A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

5.  Characterization of an antiserum to guinea pig antithrombin III (AT III). I. Reactivity with guinea pig T lymphocytes.

Authors:  L T Clement; U Yamashita; E M Shevach
Journal:  J Immunol       Date:  1981-09       Impact factor: 5.422

6.  Analysis of the effect of mast cell granules on lymphocyte blastogenesis in the absence and presence of mitogens: identification of heparin as a granule-associated suppressor factor.

Authors:  M Frieri; D D Metcalfe
Journal:  J Immunol       Date:  1983-10       Impact factor: 5.422

7.  Identification of a membrane-associated interleukin 1 in macrophages.

Authors:  E A Kurt-Jones; D I Beller; S B Mizel; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

8.  Cloning and expression of murine interleukin-1 cDNA in Escherichia coli.

Authors:  P T Lomedico; U Gubler; C P Hellmann; M Dukovich; J G Giri; Y C Pan; K Collier; R Semionow; A O Chua; S B Mizel
Journal:  Nature       Date:  1984 Nov 29-Dec 5       Impact factor: 49.962

9.  Monocyte procoagulant activity in Whipple's disease.

Authors:  C A Ottaway; R E Warren; F G Saibil; L S Fung; D S Fair; G A Levy
Journal:  J Clin Immunol       Date:  1984-09       Impact factor: 8.317

10.  Monocytes can be induced by lipopolysaccharide-triggered T lymphocytes to express functional factor VII/VIIa protease activity.

Authors:  B P Tsao; D S Fair; L K Curtiss; T S Edgington
Journal:  J Exp Med       Date:  1984-04-01       Impact factor: 14.307

View more
  15 in total

1.  Activation of blood coagulation factor IX by gingipains R, arginine-specific cysteine proteinases from Porphyromonas gingivalis.

Authors:  T Imamura; S Tanase; T Hamamoto; J Potempa; J Travis
Journal:  Biochem J       Date:  2001-01-15       Impact factor: 3.857

2.  Thrombin induces apoptosis in cultured neurons and astrocytes via a pathway requiring tyrosine kinase and RhoA activities.

Authors:  F M Donovan; C J Pike; C W Cotman; D D Cunningham
Journal:  J Neurosci       Date:  1997-07-15       Impact factor: 6.167

3.  Recombinant human factor VIIa for alveolar hemorrhage following allogeneic stem cell transplantation.

Authors:  Jason M Elinoff; Ulas Bagci; Brad Moriyama; Jennifer L Dreiling; Brent Foster; Nicole J Gormley; Rachel B Salit; Rongman Cai; Junfeng Sun; Andrea Beri; Debra J Reda; Farhad Fakhrejahani; Minoo Battiwalla; Kristin Baird; Jennifer M Cuellar-Rodriguez; Elizabeth M Kang; Stephen Z Pavletic; Dan H Fowler; A John Barrett; Jay N Lozier; David E Kleiner; Daniel J Mollura; Richard W Childs; Anthony F Suffredini
Journal:  Biol Blood Marrow Transplant       Date:  2014-03-20       Impact factor: 5.742

Review 4.  [Thrombin generation in critical illnesses].

Authors:  S Petros; R Siegemund
Journal:  Med Klin Intensivmed Notfmed       Date:  2011-10-21       Impact factor: 0.840

5.  YD-3, a novel inhibitor of protease-induced platelet activation.

Authors:  C C Wu; S W Huang; T L Hwang; S C Kuo; F Y Lee; C M Teng
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

6.  Inhibition of trypsin-like cysteine proteinases (gingipains) from Porphyromonas gingivalis by tetracycline and its analogues.

Authors:  T Imamura; K Matsushita; J Travis; J Potempa
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

7.  Activation of coagulation by administration of recombinant factor VIIa elicits interleukin 6 (IL-6) and IL-8 release in healthy human subjects.

Authors:  Evert de Jonge; Philip W Friederich; George P Vlasuk; William E Rote; Margaretha B Vroom; Marcel Levi; Tom van der Poll
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

8.  Activated factor X signaling via protease-activated receptor 2 suppresses pro-inflammatory cytokine production from lipopolysaccharide-stimulated myeloid cells.

Authors:  Eimear M Gleeson; James S O'Donnell; Emily Hams; Fionnuala Ní Áinle; Bridget-Ann Kenny; Padraic G Fallon; Roger J S Preston
Journal:  Haematologica       Date:  2013-07-19       Impact factor: 9.941

9.  Anticoagulant pretreatment attenuates production of cytokine-induced neutrophil chemoattractant following ischemia-reperfusion of rat liver.

Authors:  N Hisama; Y Yamaguchi; K Okajima; M Uchiba; K Murakami; K Mori; S Yamada; M Ogawa
Journal:  Dig Dis Sci       Date:  1996-07       Impact factor: 3.199

Review 10.  Drotrecogin alfa (activated): a novel therapeutic strategy for severe sepsis.

Authors:  S M Pastores
Journal:  Postgrad Med J       Date:  2003-01       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.